Kratos (KTOS) officer Thomas Mills executes 10b5-1 sales totaling 5,758 shares
Rhea-AI Filing Summary
Thomas E. Mills IV, President of the C5ISR Division at Kratos Defense & Security Solutions (KTOS), reported multiple open-market sales executed under a 10b5-1 trading plan adopted June 3, 2025. On 09/02/2025 he disposed of 5,758 shares across four transactions at weighted-average prices of approximately $63.78, $65.22, $66.27 and $67.11, reducing his direct beneficial holdings from 15,150 to 9,692 shares. The filing notes portions of the post-sale holdings include 232 shares from the Employee Stock Purchase Plan and approximately 3,702 shares held in the 401(k) plan. The Form 4 was signed by an attorney-in-fact on 09/04/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine director/officer sales under a pre-established 10b5-1 plan; provides liquidity but not necessarily a signal about company fundamentals.
The reported sales were executed pursuant to a 10b5-1 trading plan adopted on June 3, 2025, which typically limits the informational content of insider transactions because trades are pre-specified. The total of 5,758 shares sold in multiple tranches across narrow price ranges suggests systematic disposal rather than opportunistic timing. Post-transaction holdings still include shares from ESPP and 401(k) plans, indicating continued ownership alignment with employees. For governance review, documentation of the 10b5-1 plan adoption date and any cooling-off period are relevant; the filing discloses the adoption date but not plan terms, which is common on Form 4.
TL;DR: Insider sales are material to monitor but here appear procedural and limited in scale relative to institutional volumes.
Sales totaled 5,758 shares at weighted-average prices falling between roughly $63.24 and $67.11 per footnote ranges. The step-down in reported beneficial ownership from 15,150 to 9,692 shares is explicit. Because transactions were under a 10b5-1 plan, they likely do not reflect contemporaneous views on KTOS fundamentals; however, investors often interpret repeated officer sales as a liquidity event. The filing provides specific share counts and price ranges but does not disclose the dollar value aggregated across trades; that can be calculated from the weighted-average prices provided if needed.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 300 | $63.7767 | $19K |
| Sale | Common Stock | 3,375 | $65.2248 | $220K |
| Sale | Common Stock | 1,983 | $66.2668 | $131K |
| Sale | Common Stock | 100 | $67.11 | $7K |
Footnotes (1)
- This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 3, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.24 to $64.05 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.79 to $65.67 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.90 to $66.75 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Includes 232 shares purchased through Issuer's Employee Stock Purchase Plan and approximately 3,702 shares held through Issuer's 401(k) Plan.
